Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Lafutidine (FRG-8813) is a newly developed histamine H(2)-receptor antagonist, which can inhibit gastric acid secretion.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | In stock | $ 41.00 | |
50 mg | In stock | $ 66.00 | |
100 mg | In stock | $ 98.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | Lafutidine (FRG-8813) is a newly developed histamine H(2)-receptor antagonist, which can inhibit gastric acid secretion. |
Synonyms | FRG-8813 |
Molecular Weight | 431.55 |
Formula | C22H29N3O4S |
CAS No. | 118288-08-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 80 mg/mL (185.4 mM)
Ethanol: 11 mg/mL (25.5 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lafutidine 118288-08-7 GPCR/G Protein Immunology/Inflammation Neuroscience Histamine Receptor 5-HT Receptor inhibit gastric mucus antiulcer reflux mucosal antisecretory Inhibitor histamine protective disease secretion FRG 8813 colonic FRG8813 receptor gastroesophageal FRG-8813 inhibitor